• 1
    Harden C. Safety profile of levetiracetam. Epilepsia 2001;92(suppl 4):369.
  • 2
    Betts J, Waegemans T, Craeford SP. A multicenter, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure 2000;9: 807.
  • 3
    Krakow K, Walker M, Ojoul C, Sander JW. Long-term continuation of levetiracetam in patients with refractory epilepsy. Neurology 2001;56: 17724.
  • 4
    Schuer ML, Van Cott AC. Antiepileptic drugs. In: RowlandLP, ed. Current neurologic drugs. 3d ed. Philadelphia: Lippincott Williams & Wilkins, 2000: 1589.
  • 5
    Grant R, Shorvon SD. Efficacy and tolerability of 1000-4000 mg/day of levetiracetam as add-on therapy in patients with refractory epilepsy. Epilepsy Res 2000;42: 8995.
  • 6
    Shorvon SD, Löwenthal A, Janz P, Bielen E, Losseau P, and the European Levetiracetam Study Group. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia 2000;41: 117986.
  • 7
    Benbadis S, Chelune GJ, Stanford LD, Comair, YG. Outcome and complications of epilepsy surgery. In: WyllieE, ed. The treatment of epilepsy. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 1199.
  • 8
    Cramer JA, Ben-Menachem E, French J. Review of treatment options for refractory epilepsy: now medications and vagal nerve stimulation. Epilepsy Res 2001;47: 1725.
  • 9
    Cramer JA, Arrigoc, Vanltammee G, Gauer LJ, Lerreghino JJ. Effect of levetiracetam on epilepsy-related quality of life. Epilepsia 2000;41: 86874.
  • 10
    Cramer JA, Fisher R, Ben-Menachem E, French J, Mattson RW. New antiepileptic drugs: comparison of key clinical trials. Epilepsia 1999;40: 590600.
  • 11
    Marson AG, Kardir AZ, Chadwick DW, et al. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38: 85980.
  • 12
    Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial seizures: a randomized active control trial. Neurology 1998;51: 4855.
  • 13
    Mayanagi Y, Watanabe E, Nagahori Y, Nanhai M. Psychiatric and neuropsychological problems in epilepsy surgery: analysis of 100 cases that underwent surgery. Epilepsia 2001;42(suppl 6):1923.
  • 14
    Jensen I, Larson K. Mental aspects of temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 1979;42: 25665.
  • 15
    Shewin J. The effect of the location of an epileptogenic lesion on the occurrence of psychosis in epilepsy. Adv Biol Psychiatry 1982;81: 8197.